A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

NCT01770613 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Corporate business decision, may consider different subject population

Conditions

ST Segment Elevation Myocardial Infarction (STEMI)
Allogeneic Mesenchymal Bone Marrow Cells

Interventions

BIOLOGICAL: Stem cells

Sponsor

Stemedica Cell Technologies, Inc.

Collaborators

[object Object]